Medical Research · MA
The Adenoid Cystic Carcinoma Research
The Adenoid Cystic Carcinoma Research reported paying Jeffrey A Kaufman, Executive Director/board C, $150,000 in total compensation (FY 2023).
That places Jeffrey A Kaufman at approximately the 50th percentile among 18 similarly sized medical research nonprofits (median $131,997).
$1,893,545Total revenue (FY 2023)
$150,000Total executive compensation
50thPercentile vs. peers
Setting executive pay for this board?
Generate a board-ready comparability report for The Adenoid Cystic Carcinoma Research — named comparables, percentiles, methodology, and the 26 CFR 53.4958-6 minutes language a board can use toward the rebuttable presumption.
Build the comparability report →Comparable medical research nonprofits
Compensation is normalized to MA cost of living (BEA Regional Price Parities); each organization's reported figure is on its linked 990.
| Organization | State | Revenue | Total comp |
|---|---|---|---|
| Food Allergy Fund | NY | $1,915,611 | $293,018 |
| Paris Brain Institute America Inc | NY | $1,985,780 | $19,534 |
| Orthopaedic Foot & Ankle Foundation | IL | $1,701,279 | $42,806 |
| Fox Chase Cancer Center Foundation | PA | $2,092,287 | $67,237 |
| Runway To Hope Inc | FL | $1,672,877 | $90,637 |
| American Foundation For Children | PA | $1,661,871 | $75,454 |
| Hope For Henry Foundation | DC | $1,607,431 | $292,330 |
| The Donna Foundation Inc | FL | $1,605,859 | $101,335 |